Literature DB >> 21082358

Clinicopathological assessment of locally recurrent rectal cancer and relation to local re-recurrence.

Mamoru Uemura1, Masataka Ikeda, Hirofumi Yamamoto, Kotaro Kitani, Masayoshi Tokuoka, Ken Matsuda, Yuki Hata, Tsunekazu Mizushima, Ichiro Takemasa, Mitsugu Sekimoto, Ko Hosokawa, Nariaki Matsuura, Yuichiro Doki, Masaki Mori.   

Abstract

BACKGROUND: Local re-recurrence after R0 resection of local recurrence of rectal cancer (LRRC) is not rare. The purpose of this study was to examine the pathological features of LRRC and determine the prognostic factors.
METHODS: Twenty-one patients underwent R0 resection of LRRC without preoperative therapy from 2000 to 2008. Tumor progression patterns were classified into three types: A, expanding type; B, infiltrating type; and C, intermediate type. Distant isolated cancer cells (DICCs) were defined as cancer cells present in isolation and at a distance (>1 mm) from the tumor edge.
RESULTS: Venous invasion was identified in all but one patient (95%). DICCs were observed in 11 of 21 cases. Type A patients had a significantly lower local re-recurrence rate (0/5) compared with type B and/or C patients (11/16, P = 0.012) and a significantly lower incidence of distant metastasis compared with type B and C patients (0/5 vs. 13/16, respectively; P = 0.0028). Multivariate regression analysis identified venous invasion of the primary lesion (P = 0.027) and tumor progression patterns (P = 0.039) as independent predictors of local re-recurrence.
CONCLUSIONS: The main features of LRRC were infiltrating growth, venous invasion, and DICCs. Tumor progression patterns correlated with local re-recurrence and distant metastasis. Preoperative adjuvant therapy to terminate peri-tumor cancer cells may be required for better tumor control.

Entities:  

Mesh:

Year:  2010        PMID: 21082358     DOI: 10.1245/s10434-010-1435-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  5 in total

1.  Postoperative pain management after concomitant sacrectomy for locally recurrent rectal cancer.

Authors:  Masatoshi Kitakaze; Mamoru Uemura; Yuta Kobayashi; Masakatsu Paku; Masaaki Miyo; Yusuke Takahashi; Masakazu Miyake; Takeshi Kato; Masataka Ikeda; Shiki Fujino; Takayuki Ogino; Norikatsu Miyoshi; Hidekazu Takahashi; Hirofumi Yamamoto; Tsunekazu Mizushima; Mitsugu Sekimoto; Yuichiro Doki; Hidetoshi Eguchi
Journal:  Surg Today       Date:  2022-06-04       Impact factor: 2.549

2.  Salvage high-dose-rate interstitial brachytherapy for locally recurrent rectal cancer: long-term follow-up results.

Authors:  Masahiro Morimoto; Fumiaki Isohashi; Yasuo Yoshioka; Osamu Suzuki; Yuji Seo; Toshiyuki Ogata; Yuichi Akino; Masahiko Koizumi; Kazuhiko Ogawa
Journal:  Int J Clin Oncol       Date:  2013-06-01       Impact factor: 3.402

3.  Impact of the preoperative prognostic nutritional index as a predictor for postoperative complications after resection of locally recurrent rectal cancer.

Authors:  Masakatsu Paku; Mamoru Uemura; Masatoshi Kitakaze; Shiki Fujino; Takayuki Ogino; Norikatsu Miyoshi; Hidekazu Takahashi; Hirofumi Yamamoto; Tsunekazu Mizushima; Yuichiro Doki; Hidetoshi Eguchi
Journal:  BMC Cancer       Date:  2021-04-20       Impact factor: 4.638

4.  The efficiency of 18F-FDG-PET/CT in the assessment of tumor response to preoperative chemoradiation therapy for locally recurrent rectal cancer.

Authors:  Mamoru Uemura; Masataka Ikeda; Rio Handa; Katsuki Danno; Junichi Nishimura; Taishi Hata; Ichiro Takemasa; Tsunekazu Mizushima; Hirofumi Yamamoto; Mitsugu Sekimoto; Yuichiro Doki; Hidetoshi Eguchi
Journal:  BMC Cancer       Date:  2021-10-21       Impact factor: 4.430

Review 5.  Surgical treatment of locally recurrent rectal cancer: a narrative review.

Authors:  Zhaoya Gao; Jin Gu
Journal:  Ann Transl Med       Date:  2021-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.